Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;150(3):221-227.
doi: 10.4103/ijmr.IJMR_752_19.

Anti-thymocyte globulin in haematology: Recent developments

Salahuddin Siddiqui  1 , Jessica Cox  2 , Roger Herzig  1 , Senthilnathan Palaniyandi  1 , Gerhard C Hildebrandt  1 , Reinhold Munker  1
Affiliations
Review

Anti-thymocyte globulin in haematology: Recent developments

Salahuddin Siddiqui et al. Indian J Med Res. 2019 Sep.

Abstract

Anti-thymocyte globulin (ATG) is a polyclonal antiserum introduced into clinical medicine more than 30 years ago. It induces a broad non-specific immunosuppression. In haematology, standard indications are severe aplastic anaemia and prophylaxis and treatment of graft-versus-host disease (GVHD) (after allogeneic transplantation). For aplastic anaemia, ATG from horses has been found to be superior to ATG from rabbits. In the situation of allogeneic transplantation, ATG lessens the risk of chronic GVHD but may not improve survival. There is current controversy regarding which patients benefit most from ATG and what the ideal dosage is. It is likely that in the coming years a more specific immunosuppressive will be developed that will minimize GVHD while maintaining the graft-versus-malignancy effect.

Keywords: Anti-thymocyte globulin - graft-versus-host disease - immunosuppressive effect - myelodysplastic syndrome - severe aplastic anaemia.

PubMed Disclaimer

Conflict of interest statement

None

References

    1. Antilymphocyte serum. Br Med J. 1967;1:516–7. - PMC - PubMed
    1. Levey RH, Medawar PB. Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A. 1966;56:1130–7. - PMC - PubMed
    1. Sell S. Antilymphocytic antibody: Effects in experimental animals and problems in human use. Ann Intern Med. 1969;71:177–96. - PubMed
    1. Mathé G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M, et al. Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J. 1970;2:131–6. - PMC - PubMed
    1. Storb R, Gluckman E, Thomas ED, Buckner CD, Clift RA, Fefer A, et al. Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood. 1974;44:56–75. - PubMed